Literature DB >> 19428114

Acute renal failure during sepsis: potential role of cell cycle regulation.

Quan-Hui Yang1, Da-Wei Liu, Yun Long, Hong-Zhong Liu, Wen-Zhao Chai, Xiao-Ting Wang.   

Abstract

OBJECTIVES: This study aimed to evaluate cell cycle regulation in acute kidney injury after intraperitoneal sepsis in rats.
METHODS: Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in rats. At 0, 6, 12, 24, 48, and 72 h after CLP, serum creatinine was evaluated. DNA content of isolated kidney cells was analyzed using flow cytometer. Furthermore, the expression of p21, p53, cyclin D1, cyclin E, CDK2, CDK4 and P-pRb was also measured by western blot.
RESULTS: After sepsis-induced by CLP, kidney injury of rat was associated with G1 cell cycle arrest, however, recovery of renal function related to cell cycle progression 48h after CLP. Results also showed that the upregulation of p53 and p21 was correlated with G1 cell arrest in 48h after CLP. Nevertheless, upregulation of cyclin D1/CDK4 and cyclin E/CDK2 induced pRb phosphorylation, which resulted in the G1/S transition 48 h after CLP.
CONCLUSION: The data suggest that G1 cell cycle arrest may play a role in the initiation of kidney injury, whereas, through regulating cell cycle, p53, p21, CDKs, cyclins and P-pRb may be involved in the injury or recovery of renal function after intraperitoneal sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428114     DOI: 10.1016/j.jinf.2009.04.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  44 in total

Review 1.  A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

Authors:  Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

Review 2.  Mechanisms of Organ Dysfunction in Sepsis.

Authors:  Rachel Pool; Hernando Gomez; John A Kellum
Journal:  Crit Care Clin       Date:  2017-10-18       Impact factor: 3.598

Review 3.  Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.

Authors:  E V Schrezenmeier; J Barasch; K Budde; T Westhoff; K M Schmidt-Ott
Journal:  Acta Physiol (Oxf)       Date:  2016-08-25       Impact factor: 6.311

4.  Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia.

Authors:  Ahmed Saad; Wei Wang; Sandra M S Herrmann; James F Glockner; Michael A Mckusick; Sanjay Misra; Haraldur Bjarnason; Lilach O Lerman; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2016-07-29       Impact factor: 5.992

Review 5.  Major comorbid disease processes associated with increased incidence of acute kidney injury.

Authors:  Salwa Farooqi; Jeffrey G Dickhout
Journal:  World J Nephrol       Date:  2016-03-06

Review 6.  Emerging therapeutic targets of sepsis-associated acute kidney injury.

Authors:  Sundararaman Swaminathan; Mitchell H Rosner; Mark D Okusa
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

7.  G1 cell cycle arrest signaling in hepatic injury after intraperitoneal sepsis in rats.

Authors:  Quan-hui Yang; Da-wei Liu; Xiao-ting Wang; Rong-li Yang; Yan Shi; Yun Long; Hong-zhong Liu; Huai-wu He; Xiang Zhou; Bo Tang
Journal:  Inflamm Res       Date:  2011-04-27       Impact factor: 4.575

Review 8.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

Review 9.  Sepsis-induced acute kidney injury.

Authors:  Hernando Gómez; John A Kellum
Journal:  Curr Opin Crit Care       Date:  2016-12       Impact factor: 3.687

Review 10.  Sepsis and Acute Kidney Injury.

Authors:  Beliz Bilgili; Murat Haliloğlu; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.